Development Officer Colin Meyer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Operator
Ladies and gentlemen, thank you for standing by and welcome to the Reata Pharmaceuticals Fourth Quarter Financial and Full Year 2020 Financial Results and Update on Development Programs Conference Call. An audio recording of today s webcast will be available shortly after the call today on Reata s website at reatapharma.com in the Investors section.
Before the company proceeds with its remarks, please note that forward-looking statements disclosed in the company s press release. The company will be making forward-looking statements on today s call and there are many factors that could cause results to differ from expectations including those noted in the company s SEC filings. Today s statements are no guarantees of future outcomes. Please also note that any comments made on today s call apply only as of today March 1, 2021 and may no longer be accurate at the time of any webcast replay or transcript reading. Following the prepared remarks, we will open the call u ....

Colin Meyer , Manmeet Soni , Reata Pharmaceuticals Fourth Quarter Financial , Reata Pharmaceuticals Inc , Development Programs Conference Call , Research Development , Reata Pharmaceuticals , Full Year , Development Programs Conference , Chief Executive Officer , Warren Huff , Chief Research , Development Officer Colin Meyer , Chief Operating Officer , Chief Financial Officer , Autosomal Dominant Polycystic Kidney , Development Officer , Executive Vice , கொலின் மேயர் , மண்மீட் சோனி , றேதத மருந்துகள் நான்காவது காலாண்டு நிதி , றேதத மருந்துகள் இன்க் , வளர்ச்சி ப்ரோக்ர்யாம்ஸ் மாநாடு அழைப்பு , ஆராய்ச்சி வளர்ச்சி , றேதத மருந்துகள் , முழு ஆண்டு ,